A detailed history of Manufacturers Life Insurance Company, The transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 13,618 shares of STOK stock, worth $163,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,618
Previous 13,964 2.48%
Holding current value
$163,824
Previous $188,000 11.17%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$12.24 - $15.92 $4,235 - $5,508
-346 Reduced 2.48%
13,618 $167,000
Q2 2024

Aug 14, 2024

BUY
$11.03 - $17.52 $21,993 - $34,934
1,994 Added 16.66%
13,964 $188,000
Q1 2024

May 14, 2024

BUY
$4.12 - $14.17 $222 - $765
54 Added 0.45%
11,970 $161,000
Q3 2023

Nov 15, 2023

SELL
$3.78 - $11.99 $133,641 - $423,906
-35,355 Reduced 74.79%
11,916 $46,000
Q2 2023

Aug 11, 2023

BUY
$7.93 - $13.82 $16,803 - $29,284
2,119 Added 4.69%
47,271 $502,000
Q4 2022

Aug 11, 2023

SELL
$7.07 - $15.69 $233 - $517
-33 Reduced 0.07%
45,152 $416,000
Q4 2022

Feb 13, 2023

SELL
$7.07 - $15.69 $233 - $517
-33 Reduced 0.07%
45,152 $416,000
Q3 2022

Aug 11, 2023

SELL
$12.56 - $22.53 $4,320 - $7,750
-344 Reduced 0.76%
45,185 $580,000
Q3 2022

Nov 03, 2022

SELL
$12.56 - $22.53 $4,320 - $7,750
-344 Reduced 0.76%
45,185 $587,000
Q2 2022

Aug 11, 2023

BUY
$10.36 - $23.93 $114,270 - $263,947
11,030 Added 31.97%
45,529 $601,000
Q2 2022

Aug 15, 2022

BUY
$10.36 - $23.93 $114,270 - $263,947
11,030 Added 31.97%
45,529 $603,000
Q1 2022

Aug 11, 2023

SELL
$17.19 - $26.1 $183,125 - $278,043
-10,653 Reduced 23.59%
34,499 $726,000
Q1 2022

May 20, 2022

BUY
$17.19 - $26.1 $405,649 - $615,907
23,598 Added 216.48%
34,499 $755,000
Q4 2021

Feb 16, 2022

BUY
$18.11 - $30.72 $3,947 - $6,696
218 Added 2.04%
10,901 $262,000
Q3 2021

Nov 12, 2021

SELL
$23.65 - $34.44 $17,903 - $26,071
-757 Reduced 6.62%
10,683 $272,000
Q2 2021

Aug 12, 2021

BUY
$30.53 - $41.09 $99,039 - $133,295
3,244 Added 39.58%
11,440 $385,000
Q1 2021

May 03, 2021

BUY
$36.08 - $69.81 $10,824 - $20,943
300 Added 3.8%
8,196 $318,000
Q4 2020

Feb 12, 2021

BUY
$33.62 - $61.93 $9,279 - $17,092
276 Added 3.62%
7,896 $489,000
Q3 2020

Nov 09, 2020

BUY
$22.23 - $37.48 $169,392 - $285,597
7,620 New
7,620 $255,000
Q2 2020

Aug 10, 2020

SELL
$20.26 - $29.73 $214,816 - $315,227
-10,603 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$16.8 - $34.15 $178,130 - $362,092
10,603 New
10,603 $243,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $474M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.